Table 2.

Change in medication use during 1-month follow-up

Pharmacological agent	No. of patients being initiated on therapy during follow-up (%)a	No. of patients discontinuing therapy during follow-up (%)b
Aspirin	5 (8.3)	5 (0.5)
Thienopyridine	–	7 (0.7)
ACE-I/ARB	5 (2.5)	18 (2.2)
β-blocker	5 (3.9)	15 (1.7)
Statin	5 (11.1)	10 (1.0)

ACE-I/ARB indicates angiotensin-converting enzyme inhibitor or angiotensin II receptor blocker

^aAs % of patients who had not been prescribed therapy at discharge

^bAs % of patients who had received therapy at discharge